Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Nephrology

Solving the Diagnostic Puzzle: Gitelman and its Look-Alikes

At a Glance

Gitelman syndrome is diagnosed through a specific pattern of lab results: low blood potassium, low blood magnesium, metabolic alkalosis, and low urine calcium. Because it mimics other conditions like Bartter syndrome, genetic testing for the SLC12A3 gene is the gold standard for confirmation.

Getting to the bottom of a Gitelman syndrome diagnosis can be a complex process because its symptoms—low potassium and muscle weakness—overlap with several other conditions. Doctors use a combination of blood work, urine tests, and genetic confirmation to ensure they aren’t looking at a “look-alike” condition [1][2].

The Diagnostic ‘Signature’

According to the 2017 Expert Consensus Statement, a diagnosis of Gitelman syndrome is highly likely if your labs show a specific combination of four markers [1][3]:

  1. Low Blood Potassium (Hypokalemia): Usually persistent, even with supplements.
  2. Low Blood Magnesium (Hypomagnesemia): A very common finding in Gitelman, occurring in most patients [4][5].
  3. Metabolic Alkalosis: Blood that is slightly too alkaline (high pH and bicarbonate).
  4. Low Urine Calcium (Hypocalciuria): This is often considered the “hallmark” of Gitelman syndrome [6][7].

Gitelman vs. Bartter Syndrome

Bartter syndrome is the most common condition confused with Gitelman. While they look similar, there are key differences that help doctors tell them apart [8][9]:

  • Calcium Levels: In Gitelman syndrome, the kidneys hold onto calcium, leading to low calcium in the urine (hypocalciuria) [10]. In most types of Bartter syndrome, the kidneys lose calcium, leading to high calcium in the urine [6].
  • Magnesium: While low magnesium can happen in Bartter, it is usually much more severe and consistent in Gitelman syndrome [4].
  • Age of Onset: Bartter syndrome is often diagnosed in infancy or early childhood, whereas Gitelman syndrome symptoms frequently don’t appear until late childhood or adulthood [9][11].

Ruling Out ‘Pseudo-Gitelman’

“Pseudo-Gitelman” refers to situations where the blood work looks like Gitelman syndrome, but the cause is external rather than genetic [12]. Doctors must carefully rule these out to ensure the correct treatment:

  • Diuretic or Laxative Misuse: Chronic use of water pills (diuretics) or laxatives can mimic Gitelman labs perfectly. To tell the difference, doctors may check urine chloride levels. If chloride is high while you are not taking diuretics, it points toward Gitelman; if it is low, it may point toward vomiting or laxative use [13][5].
  • Eating Disorders: Chronic vomiting causes the body to lose acid and potassium, creating a biochemical profile similar to Gitelman syndrome [13][14].

The Final Confirmation: Genetic Testing

Genetic testing is now considered the “gold standard” for confirming Gitelman syndrome [1][15]. The test looks for mutations in the SLC12A3 gene [16].

  • Biallelic Mutations (two mutated genes): Most patients have two mutated genes (one inherited from each parent), which provides a definitive diagnosis [1].
  • Monoallelic Variants (one mutated gene): Some patients only show one mutated copy of the SLC12A3 gene but still have all the symptoms. In these cases, doctors may use more advanced testing (like MLPA) or a Thiazide (HCT) Challenge Test to see how the kidney’s “pumps” respond to medication [17][18].

Empowering yourself to understand these labs can help you work with your doctor to ensure your diagnosis is accurate and that you aren’t being mismanaged for a condition you don’t actually have [2].

Common questions in this guide

How is Gitelman syndrome diagnosed?
Doctors diagnose Gitelman syndrome by looking for a specific pattern in your lab work, including low blood potassium, low blood magnesium, metabolic alkalosis, and low urine calcium. Genetic testing is usually performed to confirm the diagnosis.
What is the difference between Gitelman and Bartter syndrome?
While both conditions cause low potassium, Gitelman syndrome typically features low calcium levels in the urine, whereas Bartter syndrome causes high urine calcium. Additionally, Gitelman syndrome symptoms often appear later in life, while Bartter is usually diagnosed in early childhood.
What is Pseudo-Gitelman?
Pseudo-Gitelman happens when your blood work looks exactly like Gitelman syndrome, but the cause is external rather than genetic. It is most commonly caused by chronic vomiting, eating disorders, or the frequent misuse of diuretics and laxatives.
Why do I need a genetic test for Gitelman syndrome?
Genetic testing looks for mutations in the SLC12A3 gene and is considered the gold standard for diagnosis. It provides definitive proof of the condition, ensuring you aren't misdiagnosed with a look-alike disorder or an external cause.
What does it mean if my genetic test only shows one mutated gene?
Most patients with the condition have two mutated genes. If your test only shows one mutated copy but you have all the classic symptoms, your doctor may recommend more advanced genetic screening or a medication challenge test to observe how your kidneys respond.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my urine calcium-to-creatinine ratio? Is it below the 0.07 threshold typical for Gitelman syndrome?
  2. 2.Does my magnesium level help distinguish this from Bartter syndrome?
  3. 3.Can we proceed with genetic testing for the SLC12A3 gene to confirm the diagnosis?
  4. 4.If my genetic test only shows one mutated gene (monoallelic), does that change how you view my diagnosis or treatment?
  5. 5.Have we ruled out 'Pseudo-Gitelman' by checking my urine chloride levels while I am off any potential diuretics?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    [Expert consensus for the diagnosis and treatment of patients with Gitelman syndrome].

    Zhonghua nei ke za zhi 2017; (56(9)):712-716 doi:10.3760/cma.j.issn.0578-1426.2017.09.021.

    PMID: 28870047
  2. 2

    Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

    Blanchard A, Bockenhauer D, Bolignano D, et al.

    Kidney international 2017; (91(1)):24-33 doi:10.1016/j.kint.2016.09.046.

    PMID: 28003083
  3. 3

    A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene.

    Chen Q, Wu Y, Zhao J, et al.

    BMC nephrology 2018; (19(1)):275 doi:10.1186/s12882-018-1083-2.

    PMID: 30340552
  4. 4

    Gitelman syndrome and ectopic calcification in the retina and joints.

    Ham Y, Mack H, Colville D, et al.

    Clinical kidney journal 2021; (14(9)):2023-2028 doi:10.1093/ckj/sfab034.

    PMID: 34476088
  5. 5

    Cystic Fibrosis Presenting as Pseudo-Bartter Syndrome: An Important Diagnosis that is Missed!

    Mantoo MR, Kabra M, Kabra SK

    Indian journal of pediatrics 2020; (87(9)):726-732 doi:10.1007/s12098-020-03342-8.

    PMID: 32504456
  6. 6

    Paradoxes in magnesium transport in type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis.

    Dutta P, Layton AT

    American journal of physiology. Renal physiology 2024; (327(3)):F386-F396 doi:10.1152/ajprenal.00117.2024.

    PMID: 38991009
  7. 7

    Gitelman syndrome with hypercalcemia and normomagnesemia: A case report.

    Tan Z, Liu C, Feng Z, et al.

    Medicine 2025; (104(22)):e42610 doi:10.1097/MD.0000000000042610.

    PMID: 40441233
  8. 8

    The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing.

    Stevenson M, Pagnamenta AT, Mack HG, et al.

    Journal of the Endocrine Society 2022; (6(7)):bvac079 doi:10.1210/jendso/bvac079.

    PMID: 35668994
  9. 9

    Clinical Course and Prognosis of Tubulopathies Characterized by Metabolic Alkalosis in Children.

    Huseynli B, Atmış B, Cevizli D, et al.

    Turkish archives of pediatrics 2022; (57(6)):644-650 doi:10.5152/TurkArchPediatr.2022.22124.

    PMID: 36314956
  10. 10

    A novel homozygous mutation (p.N958K) of SLC12A3 in Gitelman syndrome is associated with endoplasmic reticulum stress.

    Tang W, Huang X, Liu Y, et al.

    Journal of endocrinological investigation 2021; (44(3)):471-480 doi:10.1007/s40618-020-01329-y.

    PMID: 32642858
  11. 11

    Pseudo-Gitelman Syndrome Presenting with Hypokalemic Metabolic Alkalosis and Hypocalciuria.

    Lee SH, Lee S, Kim H, Kim GH

    Electrolyte & blood pressure : E & BP 2023; (21(2)):72-76 doi:10.5049/EBP.2023.21.2.72.

    PMID: 38152600
  12. 12

    A case of pseudo-Bartter/Gitelman syndrome caused by long-term laxative abuse, leading to end-stage kidney disease.

    Kondo A, Yoshiya K, Sakakibara N, et al.

    CEN case reports 2024; (13(5)):326-329 doi:10.1007/s13730-024-00851-9.

    PMID: 38306007
  13. 13

    Nephrocalcinosis fortuitously discovered: the role of surreptitious self administration of diuretics.

    Sablón-González N, Morán-Calcedo L, Alonso-Ortiz MB, et al.

    Caspian journal of internal medicine 2024; (15(1)):184-187 doi:10.22088/cjim.15.1.22.

    PMID: 38463929
  14. 14

    Gut It Out: Laxative Abuse Mimicking Distal Renal Tubular Acidosis.

    Sidler M, Mohebbi N, Hoorn EJ, Wagner CA

    Kidney & blood pressure research 2019; (44(5)):1294-1299 doi:10.1159/000501855.

    PMID: 31480048
  15. 15

    Gitelman Syndrome: A Rare Case of Hypokalaemia and a Novel Mutation.

    Matos C, Correia F, da Silva IN, et al.

    European journal of case reports in internal medicine 2021; (8(1)):002182 doi:10.12890/2021_002182.

    PMID: 33585337
  16. 16

    A NOVEL COMPOUND HETEROZYGOUS VARIANT OF SLC12A3 GENE IN A PEDIGREE WITH GITELMAN SYNDROME CO-EXISTENT WITH THYROID DYSFUNCTION.

    Liu S, Ke J, Zhang B, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(10)):889-893 doi:10.4158/EP-2018-0218.

    PMID: 30084681
  17. 17

    Spectrum of variants in a large Chinese Gitelman syndrome cohort.

    Mou L, Tang M, Zhu L, et al.

    Clinical genetics 2023; (104(6)):674-678 doi:10.1111/cge.14422.

    PMID: 37702302
  18. 18

    Case report: Gitelman syndrome with diabetes: Confirmed by both hydrochlorothiazide test and genetic testing.

    Yang L, Fan J, Liu Y, et al.

    Medicine 2023; (102(24)):e33959 doi:10.1097/MD.0000000000033959.

    PMID: 37327293

This page explains the diagnostic process for Gitelman syndrome for educational purposes only. Always consult your nephrologist or healthcare provider to interpret your specific laboratory and genetic test results.

Get notified when new evidence is published on Gitelman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.